Cure & Immunotherapies
This Think Tank develops and tests targeted immunotherapies and therapeutic vaccines to decrease viral reservoirs and find cures for HIV and hepatitis B, and vaccines for syphilis, HPV, and hepatitis C.
News
-
The Cannabis Conundrum
A Brief History of Medical Cannabis in Canada For centuries, cannabis has been used as a medicinal plant.…
-
Age, altruism, or a long-term view: Why do people living with HIV get the COVID-19 vaccine?
Understanding COVID-19 vaccine confidence in people living with HIV in Canada
Resources
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
Studies
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
-
CTNPT 047: Letermovir in ART-treated HIV-infected persons
Influence of a 3-month letermovir treatment on gut inflammation in ART-treated HIV-infected persons in an open labelled controlled randomized study
-
CTN 247: Canadian cohort of HIV+ slow progressors
A study of host and viral factors associated with disease progression in long term HIV infected subjects
-
CTN 246: Chloroquine to reduce T cell immune activation in HIV-infected individuals
Chloroquine as a modulator of T cell immune activation to improve CD4 recovery in HIV-infected participants receiving antiretroviral therapy: A proof-of-concept study
Publications
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.